Pathological gambling and nicotine dependence clinical case discussion

Journal of Addiction Medicine

Volumn 3, Issue 3, 2009, Pages 120-127

  Grant, Jon E ^a   Black, Donald W ^b   Stein, Dan J ^c   Potenza, Marc N ^d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c STELLENBOSCH UNIVERSITY   (South Africa)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70349235424     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0b013e3181a1cc36     Document Type: Article

References (74)

1. National Opinion Research Center at the University of Chicago (NORC). Gambling Impact and Behavior Study. Report to: National Gambling Impact Study Commission, April 1, 1999. Accessed March 27, 1999.
2. Cunningham-Williams R, Cottler LB. The epidemiology of pathological gambling. Semin Clin Neuropsychiatry. 2001;6:155-166.
3. Tavares H, Zilberman ML, Beites FJ, et al. Gender differences in gambling progression. J Gambl Stud. 2001;17:151-159.
4. Aasved M.The Psychodynamics and Psychology of Gambling. Spring field, IL:C Thomas; 2002.
5. Blaszczynski A, McConaghy N. Anxiety and/or depression in the pathogenesis of addictive gambling. Int J Addictions. 1989;24:337-350.
6. Custer R. When Luck Runs Out. New York: Facts on File; 1985.
7. Blaszczynski A, Nower L. Pathways model of problem and pathological gambling. Addiction. 2002;97:487-499.
8. Black DW, Arndt S, Coryell WH, et al. Bupropion in the treatment of pathological gambling: a randomized, placebo-controlled, flexible-dose study. J Clin Psychopharmacol. 2007;27:143-150.
9. Black DW, Monahan P, Temkit M, et al. A family study of pathological gambling. Psychiatry Res. 2006;141:295-303.
10. Wulfert E, Blanchard B, Friedenberg BM, et al. Retaining pathological gamblers in cognitive behavior therapy through motivational enhanement:a pilot study. Psychol Addict Behav. 2006;12:127-135.
11. Saiz-Ruiz J, Blanco C, Ibanez A, et al. Sertraline treatment of pathological gambling. J Clin Psychiatry. 2005;66:28-33.
12. Argo T, Black DW. The characteristics of pathological gambling. In: Grant JE, Potenza MN, eds. Understanding and Treating Pathological Gambling. Washington, DC: American Psychiatric Publishing, Inc.; 2004:39-54.
13. Shaw M, Forbush K, Schlinder J, et al. The effect of pathological gambling on families, marriages, and children. CNS Spectr. 2007;12: 615-622.
14. Ladouceur R, Jacques C, Giroux I, et al. Analysis of a casino's self- exclusion program. J Gamb Stud. 2000;16:453-460.
15. Brown RIF. The effectiveness of gamblers anonymous. In: Edington WR, ed. The Gambling Studies: Proceedings of the Sixth National Conference on Gambling and Risk Taking. Reno, NV:Bureau of Business and Economic Research, University of Nevada, Reno; 1985.
16. Morasco BJ, Pietrzak RH, Blanco C, et al. Health problems and medical utilization associated with gambling disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychosom Med. 2006;68:976-984. (Pubitemid 44808724)
17. Grant JE, Potenza MN. Tobacco use and pathological gambling. Ann Clin Psychiatry. 2005;17:237-241.
18. Potenza MN. Should addictive disorders include non-substance-related conditions? Addiction. 2006;101:142-151.
19. Petry NM. Should the scope of addictive behaviors be broadened to include pathological gambling? Addiction. 2006;101:152-160.
20. Christo G, Jones SL, Hay lett S, et al. The Shorter PROMIS Question naire-further validation of a tool for simultaneous assessment of multiple addictive behaviours. Addict Behav.2003;28:225-248.
21. du Toit PL, van Kradenburg J, Niehaus D, et al. Comparison of obsessive-compulsive disorder patients with and without comorbid putative obsessive-compulsive spectrum disorders using a structured clinical interview. Compr Psychiatry. 2001;42:291-300.
22. Pomerleau CS. Co-factors for smoking and evolutionary psychobiology Addiction. 1997;92:397-408.
23. Spinella M. Evolutionary mismatch, neural reward circuits, and pathological gambling. Int J Neurosci.2003;113:503-512.
24. Stein DJ, Grant JE. Betting on dopamine. CNS Spectr.2005;10:268-270.
25. Li MD, Cheng R, Ma JZ, et al. A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction (Abingdon, England). 2003;98:23-31.
26. Ibáñez A, Blanco C, Perez de Castro I, et al. Genetics of pathological gambling. J Gambl Stud. 2003;19:11-22.
27. Xian H, Eisen S, Scherrer J, et al. Common genetic vulnerability for pathological gambling, nicotine dependence and drug dependence in men. Behav Genet. 2007;37:807-808.
28. Oakley-Browne MA, Adams P, Mobberley PM. Interventions for pathological gambling. Cochrane Database Syst Rev 2, CD001521. 2000.
29. Grant JE, Kim SW. Medication management of pathological gambling. Minn Med. 2006;89:44-48.
30. Potenza MN, Steinberg MA, McLaughlin SD, et al. Characteristics of tobacco-smoking problem gamblers calling a gambling helpline. Am J Addict. 2004;13:471-493.
31. Stein DJ, Chamberlain SR, Fineberg N. An A- B- C model of habit disorders: hair-pulling, skin-picking, and other stereotypic conditions. CNS Spectr. 2006;11:824-827.
32. Goudriaan AE, Oosterlaan J, de Beurs E, et al .Neurocognitive functions in pathological gambling: a comparison with alcohol dependence, Tourette syndrome and normal controls. Addiction. 2006;101:534-547.
33. Desai RA, Potenza MN.Gender differences in the associations between past-year gambling problems and psychiatric disorders. Soc Psychiatry Psychiatr Epidemiol. 2008;43:173-183.
34. Lochner C, Hemmings SMJ, Kinnear CJ, et al. Cluster analysis of obsessive-compulsive spectrum disorders in patients with obsessive-compulsive disorder: clinical and genetic correlates. Compr Psychiatry. 2005;46:14-19.
35. Stein DJ, Matsunaga H. Specific phobia. A disorder of fear conditioning and extinction. CNS Spectr.2006;11:248-251.
36. Grant JE, Levine L, Kim D, et al. Impulse control disorders in adult psychiatric inpatients. Am J Psychiatry. 2005;162:2184-2188.
37. PetryNM, Stinson FS, Grant BF. Co-morbidity of DSM -IV pathological gambling and other psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2005;66:564-574.
38. Hollander E, Pallanti S, Allen A, et al Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? Am J Psychiatry.2005;162: 137-145.
39. Grant JE, Potenza MN. Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label pilot study with double-blind discontinuation. Int Clin Psychopharmacol. 2006;21:203-209.
40. Potenza MN. Alcohol and Gambling: Co-occurrence and Treatment Implications. Paper presented at the Pleasure and Motivation: Impulsivity and Compulsivity, Minneapolis, MN;2008.
41. Hollander E, Kaplan A, Pallanti S. Pharmacological treatments. In: Grant JE, Potenza MN, eds. Pathological Gambling: A Clinical Guide to Treatment. Washington, DC: American Psychiatric Press, Inc.; 2004:189-206.
42. Potenza MN. Impulse control disorders and co-occurring disorders:dual diagnosis considerations. J Dual Diagnosis. 2007;3:47-57.
43. Grant JE, Kim SW, Odlaug B. N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study. Biol Psychiatry. 2007;62:652-657.
44. Kalivas PW, Volkow ND. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry. 2005;162:1403-1413.
45. Grant JE, Kim SW, Odlaug B, et al Daily tobacco smoking in treatment- seeking pathological gamblers: clinical correlates and co-occurring psychiatric disorders. J Addict Med. 2008;2:178-184.
46. Grant JE, Desai R, Potenza MN. Influence of nicotine dependence on the associations between subsyndromal and pathological gambling and other psychiatric disorders: data from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2009:e1-e10.
47. Blanco C, Hasin DS, Petry NM, et al. Sex differences in subclinical and DSM-IV pathological gambling: results from the National Epidemio- logic Survey on Alcohol and Related Conditions. Psychol Med. 2006; 36:943-953.
48. PotenzaMN, Maciejewski PK, Mazure CM. A gender-based examination of past-year recreational gamblers. J Gambling Stud. 2006;22:41-64.
49. Potenza MN, Steinberg MA, McLaughlin S, et al. Gender-related differences in the characteristics of problem gamblers using a gambling helpline. Am J Psychiatry. 2001;158:1500-1505.
50. Grant JE, Kim SW, Hollander E, et al. Predicting response to opiate antagonists and placebo in the treatment of pathological gambling. Psychopharmacol.2008;200:521-527. Available at: http://www.springerlink. com. Accessed September 30, 2008.
51. Grant JE, Kim SW, Hartman B. A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges. J Clin Psychiatry. 2008;69:783-789.
52. Kim SW, Grant JE, Adson DE, et al. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry. 2001;49:914-921.
53. Oslin DW, Berrettini W, Kranzler HR, et al. Afunctional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychophamacology.2003;28:1546-1552.
54. Lerman C, Patterson F, Berrettini W. Treating tobacco dependence: state of the science and new directions. J Clin Oncol. 2005;23:311-323.
55. BrodyA, Saxena S, Silverman DH, et al. Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine. Psychiatry Res. 1999;91:127-139.
56. KostenTR, Scanley BE, Tucker KA, et al. Cue-induced brain activity changes and relapse in cocaine dependent patients. Neuropsychopharm..2006;31: 644-650.
57. Brewer JA, Worhunsky P, Carroll KM, et al. Pretreatment brain activation during Stroop task is associated with outcomes in cocaine-dependent patients. Biol Psychiatry. 2008;64:998 1004.
58. StreeterC, Terhune D, Whitfield T, et al. Performance on the Stroop.predicts treatment compliance in cocaine-dependent individuals. Neuro-psychopharmacology.2007;33:827-836.
59. HollanderE, DeCaria CM, Finkell JN, et al. A randomized double-blind fluvoxamine/placebo crossover trial in pathological gambling. Biol sychiatry. 2000;47:813-817.
60. Grant JE, Kim SW, Potenza MN, et al. Paroxetine treatment of pathological gambling: a multi-center randomized controlled trial. Int Clin Psychopharmacol 2003;18:243-249.
61. Slutske WS. Natural recovery and treatment-seeking in pathological gambling: results of two national surveys. Am J Psychiatry. 2006;163: 297-302.
62. TammingaCA, NestlerEJ. Pathological gambling: focusing on the addiction, not the activity. Am J Psychiatry. 2006;163:180-181.
63. Petry NM. Patterns and correlates of gamblers anonymous attendance in pathological gamblers seeking professional treatment. Addict Behav. 2003;28:1049-1062.
64. Carroll KM, Nich C, Ball SA, et al. One year follow-up of disulfiram and psychotherapy for cocaine-alcohol abusers: sustained effects of treatment. Addiction. 2000 95:1335-1349.
65. Desai RA, Desai M, Potenza MN. Gambling, health and age: data from the National Epidemiologic Survey on Alcohol and Related Conditions. psychol Addict Behav. 2007;21:431-440.
66. Pietrzak RH, Molina CA, Ladd GT, et al. Health and psychosocial correlates of disordered gambling in older adults. Am J Ger Psychiatry. 2005;13:510-519.
67. Pietrzak RH, Morasco BJ, Blanco C, et al. Gambling level and psychi atric and medical disorders in older adults: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Am J Geriatr Psychiatry. 2007;15:301-313.
68. Erickson L, Molina CA, Ladd GT, et al. Problem and pathological gambling are associated with poorer mental and physical health in older adults. Int J Geriatric Psychiatry. 2005;20:754-759.
69. Ladd GT, Petry NM. Disordered gambling among university-based medical and dental patients: a focus on internet gambling. Psychology Addict Behav2002;16:76-79.
70. Morasco BJ, vom Eigen KA, Petry NM. Severity of gambling is associated with physical and emotional health in urban primary care patient. Psychiatry Primary Care. 2006;28:94-100.
71. Pasternak AV, Fleming MF. Prevalence of gambling disorders in a primary care setting. Arch Fam Med. 1999;8:515-520.
72. Potenza MN, Voon V, Weintraub D. Drug insights: impulse control disorders and dopamine therapies in Parkinson's disease Nat Clin:.Practice Neuro. 2007;3:664-672.
73. Stinchfield R, Govoni R, Frisch GR. Screening and assessment instruments. In: Grant JE, Potenza MN, eds. Pathological Gambling: A Clinical Guide to Treatment. Washington, DC: American Psychiatric: Press, Inc.; 2004:207-258.
74. Weintraub D, Stewart S, Shea JA, et al. Validation of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease (QUIP).:Movement Disorders, in press.